Alexandra de Zwart

Mar 14, 2023

Advertising therapeutic goods in Australia (don't let your ad make you sad)

By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart

Due to a complex array of legislation, regulations and codes, advertising therapeutic goods in compliance with Australian law can be a...

Nov 14, 2022

By Nicholas Tyacke Robynne Sanders Greg Bodulovic +3 more...

Artificial intelligence (AI) is playing an increasingly relevant and important role in our lives. Be it through your personal devices,...

May 17, 2022

By Nicholas Tyacke Alexandra de Zwart Sarah McKenzie

For pharmaceutical companies, patent term extensions (PTEs) remain a fundamental means of compensating them for the erosion of the terms...

Mar 28, 2022

By Nicholas Tyacke Alexandra de Zwart Sarah McKenzie

Patent term extensions (PTEs) in Australia have been a hot topic over the past year. On Friday, things got a lot hotter for patentees...

Oct 17, 2021

By Nicholas Tyacke Alexandra de Zwart

In its second significant recent decision addressing patent term extensions (PTEs) in Australia, the Federal Court of Australia, in Merck...

Aug 20, 2021

By Nicholas Tyacke Eliza Saunders Alexandra de Zwart +1 more...

For many years, the following question awaited judicial determination under Australian law: is a DNA-based diagnostic method patent...

Aug 05, 2021

By Nicholas Tyacke Alexandra de Zwart

Artificial Intelligence (AI) and machine learning are increasingly used in the life sciences industry for research and drug discovery,...

May 12, 2021

By Nicholas Tyacke Alexandra de Zwart Holly Yuan +2 more...

The 2021-2022 Australian Federal Budget was unveiled last night (11 May 2021). Deemed the ‘COVID-19 Recovery Budget’, it includes a...